 Enveric Biosciences Inc announced it has closed the acquisition of MagicMed Industries Inc, a Canadian biotechnology firm with a library of novel derivative psychedelics molecules known as the Psybrary. The all-stock transaction sees MagicMeds CEO Joseph Tucker taking on the CEO role at Enveric, with former Enveric CEO David Johnson becoming executive chairman. 